ABVC BIOPHARMA, INC. (ABVC) › Total LiabilitiesABVC BIOPHARMA, INC. (ABVC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $34.0K2015: $369.1K2016: $6.56M2017: $4.40M2018: $11.28M2019: $7.05M2020: $8.94M2021: $4.83M2022: $6.34M2023: $6.53M2024: $6.82M2025: $7.76M$7.76M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$7.76M+13.9%2024$6.82M+4.4%2023$6.53M+3.0%2022$6.34M+31.4%2021$4.83M-46.0%2020$8.94M+26.8%2019$7.05M-37.5%2018$11.28M+156.4%2017$4.40M-32.9%2016$6.56M+1676.3%2015$369.1K+984.6%2014$34.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share